Raymond James & Associates’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,937,296
Closed -$53.3M 4145
2022
Q3
$53.3M Sell
1,937,296
-107,116
-5% -$2.65M 0.05% 303
2022
Q2
$47.1M Sell
2,044,412
-119,489
-6% -$2.79M 0.05% 336
2022
Q1
$47.2M Sell
2,163,901
-40,225
-2% -$835K 0.04% 379
2021
Q4
$47.1M Sell
2,204,126
-41,499
-2% -$870K 0.04% 402
2021
Q3
$47M Buy
2,245,625
+9,531
+0.4% +$208K 0.04% 374
2021
Q2
$51.5M Buy
2,236,094
+36,300
+2% +$835K 0.05% 340
2021
Q1
$48.6M Sell
2,199,794
-510,503
-19% -$11.8M 0.05% 327
2020
Q4
$50.5M Sell
2,710,297
-147,188
-5% -$2.42M 0.06% 287
2020
Q3
$41.5M Sell
2,857,485
-47,097
-2% -$599K 0.05% 300
2020
Q2
$32.5M Sell
2,904,582
-177,199
-6% -$1.99M 0.04% 351
2020
Q1
$30.8M Buy
3,081,781
+2,042,806
+197% +$28.6M 0.05% 317
2019
Q4
$17M Buy
1,038,975
+89,005
+9% +$1.19M 0.02% 658
2019
Q3
$11.5M Buy
+949,970
New +$13M 0.02% 798

Other funds holding CHNG

Raymond James & Associates's CHNG Position: Q4 2022 in Review

Raymond James & Associates sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 1,937,296 shares — an estimated $53.3M sold.

Raymond James & Associates first reported a position in CHNG in Q3 2019 and held it in 13 quarters. The position peaked at $53.3M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Raymond James & Associates reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 1,937,296 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $53.3M.
  • Raymond James & Associates first reported a position in Change Healthcare Inc. Common Stock in Q3 2019 and held it in 13 quarters.
  • Raymond James & Associates's Change Healthcare Inc. Common Stock position peaked at $53.3M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.